PROvenge Treatment and Early Cancer Treatment
Public ClinicalTrials.gov record NCT00779402. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Autologous PAP-loaded Dendritic Cell Vaccine (Sipuleucel-T, APC8015, Provenge®) in Patients With Non-metastatic Prostate Cancer Who Experience PSA Elevation Following Radical Prostatectomy: a Randomized, Controlled, Double-blind Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The PROTECT-PROvenge Treatment and Early Cancer Treatment trial was a Phase III trial for patients with hormone sensitive prostate cancer. The study was conducted at over 15 participating centers throughout the US. The purpose of the study was to determine if sipuleucel-T was effective for treatment of early stage, non-metastatic prostate cancer. The study compared the active vaccine to control to determine whether the product delayed the time until cancer progression.
Study identification
- NCT ID
- NCT00779402
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 176 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2001 (Type not available)
- Primary completion
- Aug 2006 (Actual)
- Completion
- May 2015 (Actual)
- Last update posted
- Jan 29, 2018
2001 – 2015
United States locations
- U.S. sites
- 18
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alta Bates Comprehensive Cancer Center | Berkeley | California | 94704 | — |
| South Orange County Medical Research | Laguna Hills | California | 92653 | — |
| University of Colorado Health Sciences Center | Aurora | Colorado | 80045-3206 | — |
| Oncology Specialists, SC | Park Ridge | Illinois | 60068-1174 | — |
| Mount Sinai School of Medicine | New York | New York | 10029 | — |
| University of Rochester Medical Center | Rochester | New York | 14642-0001 | — |
| McKay Urology | Charlotte | North Carolina | 28207 | — |
| AKSM Clinical Research Group | Columbus | Ohio | 43214 | — |
| Providence Medical Center | Portland | Oregon | 97213 | — |
| Oregon Health and Sciences University | Portland | Oregon | 97239 | — |
| Oregon Urology Institute | Springfield | Oregon | 97477 | — |
| Urology Health Specialists - Bryn Mawr | Bryn Mawr | Pennsylvania | 19010 | — |
| Albert Einstein Medical Building | Philadelphia | Pennsylvania | 19141 | — |
| Bryn Mawr Urology Group | Rosemont | Pennsylvania | 19010 | — |
| University of Tennessee | Memphis | Tennessee | 38163 | — |
| Urology of Virginia, PC | Virginia Beach | Virginia | 23462 | — |
| Virginia Mason Medical Center | Seattle | Washington | 98101 | — |
| Swedish Medical Center | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00779402, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 29, 2018 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00779402 live on ClinicalTrials.gov.